secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mirum Pharmaceuticals, Inc. (MIRM)
CIK:        0001759425
Form:       8-K
Filed at:   2023-10-13T23:59:59+00:00
Accession:  0001193125-23-256103
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mirum files updated risk factor disclosure; no financial or operational news
----------------------------------------------------------------------------

- Update includes risks related to sole-source contract manufacturers for commercial supplies.
- Lists risk of needing additional financing for commercialization and product development.
- Notes potential delays in patient enrollment and clinical trial completion.
- References the Asset Purchase and risk of not realizing its anticipated benefits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759425/000119312523256103/0001193125-23-256103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759425/000119312523256103/d424554d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-256103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer